COVID-19 and dermatology

Ülker Gül, Ülker Gül

Abstract

Background/aim: Sars-CoV-2 virus infection (COVID-19) was observed in China in the last months of 2019. In the period following, this infection spread all over the world. In March 2020 the World Health Organization announced the existence of a pandemic. The aim of this manuscript is to investigate skin diseases associated with COVID-19 under three main headings: skin problems related to personal protective equipment and personal hygiene measures, skin findings observed in SARS-CoV-2 virus infections, and skin findings due to COVID-19 treatment agents.

Materials and methods: In PubMed, Google Scholar databases, skin lesions related to personal protective equipment and personal hygiene measures, skin findings observed in SARS-CoV-2 virus infections and skin findings due to COVID-19 treatment agents subjects are searched in detail.

Results: Pressure injury, contact dermatitis, itching, pressure urticaria, exacerbation of preexisting skin diseases, and new skin lesion occurrence/new skin disease occurrence may be due to personal protective equipment. Skin problems related to personal hygiene measures could include itching, dryness, and contact dermatitis. Skin findings may also be observed in SARS-CoV-2 virus infections. The incidence of skin lesions due to COVID-19 was reported to be between 0.2% and 29%. Many skin lesions including maculopapular, urticarial, vesicular, chilblain-like, thrombotic/ischemic, etc. are observed in COVID-19 patients. Some authors have stated that there is an absence of SARS-CoV-2 virus infection-specific skin findings. However, in asymptomatic or presymptomatic COVID-19 patients in particular, skin lesions can lead to the diagnosis of COVID-19. In addition, skin lesions may occur due to COVID-19 treatment agents.

Conclusion: Many skin lesions may appear as a result of COVID-19. Even in the absence of a COVID-19 diagnosis, skin findings should be evaluated carefully in this pandemic period.

Keywords: COVID-19; SARS-CoV-2; dermatology; skin findings.

Conflict of interest statement

There are no financial conflicts of interest to disclose.

This work is licensed under a Creative Commons Attribution 4.0 International License.

References

    1. Hafeez A Ahmad S Siddqui SA Ahmad M Mishra S A review of COVID-19 (Coronavirus Disease-2019) diagnosis, treatments and prevention. Eurasian Journal of Medicine and Oncology. 2020;4:116–125.
    1. Cucinotta D Vanelli M. WHO declares COVID-19 a pandemic. Acta Bio-medica: Atenei Parmensis. 2020;91:157–160.
    1. Zhao N Zhou ZL Wu L Zhang XD Han SB An update on the status of COVID-19: a comprehensive review. European Review for Medical and Pharmacological Sciences. 2020;24:4597–4606.
    1. Nishiura H Kobayashi T Miyama T Suzuki A Jung SM Estimation of the asymptomatic ratio of novel coronavirus infections (COVID-19) International Journal of Infectious Diseases. 2020;94:154–155.
    1. Hu Z Song C Xu C Jin G Chen Y Clinical characteristics of 24 asymptomatic infections with COVID-19 screened among close contacts in Nanjing, China. Science China. Life Sciences. 2020;63:706–711.
    1. Dong X Cao YY Lu XX Zhang JJ Du H Eleven faces of coronavirus disease 2019. Allergy. 2020;10
    1. Ai T Yang Z Hou H Zhan C Chen C Correlation of chest CT and RT-PCR testing in coronavirus disease 2019 (COVID-19) in China: A report of 1014 cases. Radiology. 2020;200642
    1. Galván Casas C Català A Carretero Hernández G Rodríguez-Jiménez P Fernández Nieto Classification of the cutaneous manifestations of COVID-19: a rapid prospective nationwide consensus study in Spain with 375 cases. British Journal of Dermatology. 2020;10
    1. Zhang Z Zhang L Wang Y -19 indirect contact transmission through the oral mucosa must not be ignored. Journal of Oral Pathology & Medicine. 2020;49:450–451.
    1. Yan Y Chen H Chen L Cheng B Diao P Consensus of Chinese experts on protection of skin and mucous membrane barrier for health-care workers fighting against coronavirus disease 2019. Dermatologic Therapy. 2020;10
    1. Kwatra SG Sweren RJ Grossberg AL Dermatology practices as vectors for COVID-19 transmission: A call for immediate cessation of nonemergent dermatology visits. Journal of the American Academy of Dermatology. 2020;82:e179–e180.
    1. Gisondi P Piaserico S Conti A Naldi L Dermatologists and SARS-CoV-2: The impact of the pandemic on daily practice. Journal of the European Academy of Dermatology and Venereology. 2020;10
    1. Challenges of COVID-19 pandemic for dermatology. Dermatologic Therapy. 2020;10
    1. Borgatta L Fisher M Robbins N. Hand protection and protection from hands: hand-washing, germicides and gloves. Women & Health. 1989;15:77–92.
    1. Pei S Xue Y Zhao S Alexander N Mohamad G Occupational skin conditions on the frontline: A survey among 484 Chinese healthcare professionals caring for Covid-19 patients. Journal of the European Academy of Dermatology and Venereology. 2020;10
    1. Zuo Y Hua W Luo Y Li L Skin reactions of N95 masks and medial masks among health care personnel: A self-report questionnaire survey in China. Contact Dermatitis. 2020;10
    1. Foo CC Goon AT Leow YH Goh CL Adverse skin reactions to personal protective equipment against severe acute respiratory syndrome--a descriptive study in Singapore. Contact Dermatitis. 2006;55:291–294.
    1. Lin P Zhu S Huang Y Li L Tao J Adverse skin reactions among healthcare workers during the coronavirus disease 2019 outbreak: A survey in Wuhan and its surrounding regions. British Journal of Dermatology. 2020;10
    1. Zhang B Zhai R -19 epidemic: Skin protection for health care workers must not be ignored. Journal of the European Academy of Dermatology and Venereology. 2020;10
    1. Lan J Song Z Miao X Li H Li Y Skin damage among health care workers managing coronavirus disease-2019. Journal of the American Academy of Dermatology. 2020;82:1215–1216.
    1. Covid-19 pandemic and the skin - What should dermatologists know? Clinics in Dermatology 2020
    1. Oranges T Janowska A Dini V Reply to: “Skin damage among health care workers managing coronavirus disease-2019”. The Journal of the American Academy of Dermatology. 2020;82:e233–e234.
    1. Jiang W Cao W Liu Q. Wearing the N95 mask with a plastic handle reduces pressure injury. Journal of the American Academy of Dermatology. 2020;82:e191–192.
    1. Payne A skin damage with prolonged wear of FFP3 masks. British Medical Journal. 2020;19
    1. Gheisari M Araghi F Moravvej H Tabary M Dadkhahfar S Skin reactions to non-glove personal protective equipment: An emerging issue in the COVID-19 pandemic. Journal of the European Academy of Dermatology and Venereology. 2020;10
    1. Balato A Ayala F Bruze M Crepy MN Gonçalo M Duus Johansen European task force on contact dermatitis statement on coronavirus 19 disease (COVID-19) outbreak and the risk of adverse cutaneous reactions. Journal of the European Academy of Dermatology and Venereology. 2020;10
    1. Donovan J Kudla I Holness L Skotnicki-Grant S Nethercott J Skin reactions following use of N95 facial masks. Dermatitis. 2007;18:104–104.
    1. Donovan J Skotnicki-Grant S Allergic contact dermatitis from formaldehyde textile resins in surgical uniforms and nonwoven textile masks. Dermatitis. 2006;18:40–44.
    1. Gheisari M Araghi F Moravvej H Tabary M Dadkhahfar S Skin reactions to non-glove personal protective equipment: An emerging ıssue in the COVID-19 Pandemic. Journal of the European Academy of Dermatology and Venereology. 2020;10
    1. Abtahi-Naeini B Frequent handwashing amidst the COVID-19 outbreak: prevention of hand irritant contact dermatitis and other considerations. Health Science Reports. 2020;3
    1. Guan W Ni Z Hu Y Liang W Ou C Clinical characteristics of coronavirus disease 2019 in China. The New England Journal of Medicine. 2020;10
    1. Alramthan A Aldaraji W. A case of COVID-19 presenting in clinical picture resembling chilblains disease. First report from the Middle East. Clinical and Experimental Dermatology. 2020;10
    1. Hedou M Carsuzaa F Chary E Hainaut E Cazenave-Roblot F Comment on “Cutaneous manifestations in COVID-19: a first perspective “ by Recalcati S. Journal of the European Academy of Dermatology and Venereology. 2020;10
    1. Mahé A Birckel E Krieger S Merklen C Bottlaender L A distinctive skin rash associated with Coronavirus Disease 2019? Journal of the European Academy of Dermatology and Venereology 2020. 10
    1. Recalcati S. Cutaneous manifestations in COVID-19: a first perspective. Journal of the European Academy of Dermatology and Venereology. 2020;10
    1. Estébanez A Pérez-Santiago L Silva E Guillen-Climent S García-Vázquez A Ramón M. Cutaneous manifestations in COVID-19: a new contribution. Journal of the European Academy of Dermatology and Venereology. 2020;10
    1. Fernandez-Nieto D Jimenez-Cauhe J Suarez-Valle A Suarez-Valle A Moreno-Arrones OM Saceda-Corralo D Characterization of acute acro-ischemic lesions in non-hospitalized patients: a case series of 132 patients during the COVID-19 outbreak. Journal of the American Academy of Dermatology. 2020;10
    1. Mungmungpuntipantip R Wiwanitkit V COVID-19 and cutaneous manifestations. Journal of the European Academy of Dermatology and Venereology. 2020;10
    1. Cutaneous manifestations of COVID-19: Report of three cases and a review of literature. Journal of Dermatological Science. 2020.
    1. Morey-Olivé M Espiau M Mercadal-Hally M Lera-Carballo E García-Patos V de Pediatría (English Edition Cutaneous manifestations in the current pandemic of coronavirus infection disease (COVID 2019) 2020;10
    1. Gianotti R Veraldi S Recalcati S Cusini M Ghislanzoni M Cutaneous clinico-pathological findings in three COVID-19-positive patients observed in the metropolitan area of Milan, Italy. Acta Dermato-Venereologica. 2020;10:00015555–3490.
    1. Bouaziz JD Duong T Jachiet M Velter C Lestang P Vascular skin symptoms in COVID-19: a french observational study. Journal of the European Academy of Dermatology and Venereology. 2020;10
    1. Acute hemorrhagic edema of ınfancy after 39 coronavirus ınfection with recurrent rash. Case Reports in Pediatrics. 2017. pp. 5637503–5637503.
    1. Joob B Wiwanitkit V COVID-19 can present with a rash and be mistaken for Dengue. Journal of the American Academy of Dermatology. 2020;9622:S0190–S0190.
    1. Zhang JJ Dong X Cao YY Yuan YD Yang YB Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China. Allergy. 2020;10
    1. Henry D Ackerman M Sancelme E Finon A Esteve E. Urticarial eruption in COVID-19 infection. Journal of the European Academy of Dermatology and Venereology. 2020;10
    1. van Damme C Berlingin E Saussez S Accaputo O Acute urticaria with pyrexia as the first manifestations of a COVID-19 infection. Journal of the European Academy of Dermatology and Venereology. 2020;10
    1. Torres T Puig L Managing cutaneous immune-mediated diseases during the COVID-19 pandemic. American Journal of Clinical Dermatology. 2020;10
    1. Tammaro A Adebanjo GAR Parisella FR Pezzuto A Rello J Cutaneous manifestations in COVID-19: the experiences of Barcelona and Rome. Journal of the European Academy of Dermatology and Venereology. 2020;10
    1. Landa N Mendieta-Eckert M Fonda-Pascual P Aguirre T Chilblain-like lesions on feet and hands during the COVID-19 pandemic. International Journal of Dermatology. 2020;10
    1. Andina D Noguera-Morel L Bascuas-Arribas M Gaitero-Tristán J Alonso-Cadenas JA Chilblains in children in the setting of COVID-19 pandemic. Pediatric Dermatology. 2020;10
    1. López-Robles J de la Hera I Pardo J Martínez J Cutillas-Marco E Chilblain-like lesions: a case series of 41 patients during the COVID-19 pandemic. Clinical and Experimental Dermatology. 2020;10
    1. Recalcati S Barbagallo T Frasin LA Prestinari F Cogliardi A Acral cutaneous lesions in the Time of COVID-19. Journal of the European Academy of Dermatology and Venereology. 2020;10
    1. Torres-Navarro I Abril-Pérez C Roca-Ginés J Sánchez-Arráez J Botella-Estrada R Évole-Buselli M. Comment on ‘Two cases of COVID-19 presenting with a clinical picture resembling chilblains: first report from the Middle East’: pernio unrelated to COVID-19. Clinical and Experimental Dermatology 2020. 10
    1. Piccolo V Neri I Filippeschi C Oranges T Argenziano G Chilblain-like lesions during COVID-19 epidemic: a preliminary study on 63 patients. Journal of the European Academy of Dermatology and Venereology. 2020;10
    1. Kolivras A Dehavay F Delplace D Feoli F Meiers I Coronavirus (COVID-19) infection induced chilblains: a case report with histopathological findings. Journal of the American Academy of Dermatology Case Reports. 2020;10
    1. Zhang Y Cao W Xiao M Li YJ Yang Y Clinical and coagulation characteristics of 7 patients with critical COVID-2019 pneumonia and acro-ischemia. Zhonghua Xue Ye Xue Za Zhi. 2020;41:2727–2727.
    1. Li T Lu H Zhang W. Clinical observation and management of COVID-19 patients. Emerging Microbes & Infections. 2020;9:687–690.
    1. Zhang Y Xiao M Zhang S Xia P Cao W Coagulopathy and antiphospholipid antibodies in patients with. Covid-19. New England Journal of Medicine. 2020;382
    1. Tang N Li D Wang X Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. Journal of Thrombosis and Haemostasis. 2020;18:844–847.
    1. Jimenez-Cauhe J Ortega-Quijano D Carretero-Barrio I Suarez-Valle A Saceda-Corralo D Erythema multiforme-like eruption in patients with COVID-19 infection: clinical and histological findings. Clinical and Experimental Dermatology. 2020;10
    1. Robustelli Test E Vezzoli P Carugno A Raponi F Gianatti A Acute generalized exanthematous pustulosis with erythema multiforme-like lesions in a COVID-19 woman. Journal of the European Academy of Dermatology and Venereology. 2020;10
    1. Janah H Zinebi A Elbenaye J Atypical erythema multiforme palmar plaques lesions due to Sars-Cov-2. Journal of the European Academy of Dermatology and Venereology. 2020;10
    1. Castelnovo L Capelli F Tamburello A Maria Faggioli P Mazzone A Symmetric cutaneous vasculitis in COVID-19 pneumonia. Journal of the European Academy of Dermatology and Venereology. 2020;10
    1. Manalo IF Smith MK Cheeley J Jacobs R. A Dermatologic manifestation of COVID-19: transient livedo reticularis. Journal of the American Academy of Dermatology. 2020;10
    1. Amatore F Macagno N Mailhe M Demarez B Gaudy-Marqueste C SARS-CoV-2 infection presenting as a febrile rash. Journal of the European Academy of Dermatology and Venereology. 2020;10
    1. Cui S Chen S Li X Liu S Wang F Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia. Journal of Thrombosis and Haemostasis. 2020;10
    1. Carreras-Presas CM Sánchez JA López-Sánchez AF Jané-Salas E Somacarrera Pérez ML Oral vesiculobullous lesions associated with SARS-CoV-2 infection. Oral Diseases. 2020;10
    1. Gonzalez CD Hansen C Clarke JT Adverse cutaneous drug reactions with antimalarials in cutaneous lupus and dermatomyositis: A retrospective cohort study. Journal of the American Academy of Dermatology. 2019;81:859–860.
    1. Schwartz RA Janniger CK Generalized pustular figurate erythema: A newly delineated severe cutaneous drug reaction linked with hydroxychloroquine. Dermatologic Therapy. 2020;10
    1. Gül Ü Cakmak SK Kiliç A Gonul M Bilgili S. A case of hydroxychloroquine induced pruritus. European Journal of Dermatology. 2006;16:586–587.
    1. Salido M Joven B D’Cruz DP Khamashta MA Hughes GR Increased cutaneous reactions to hydroxychloroquine (Plaquenil) possibly associated with formulation change: comment on the letter by Alarcón. Arthritis & Rheumatology. 2002;46:3392–3396.
    1. Das A Sancheti K Podder I Das NK Azithromycin induced bullous fixed drug eruption. Indian Journal of Pharmacology. 2016;48:83–85.
    1. Sriratanaviriyakul N Nguyen LP Henderson MC Albertson TE Drug reaction with eosinophilia and systemic symptoms syndrome (DRESS) syndrome associated with azithromycin presenting like septic shock: a case report. Journal of Medical Case Reports. 2014;8:332–332.
    1. Aihara Y Ito S Kobayashi Y Aihara M Stevens-Johnson syndrome associated with azithromycin followed by transient reactivation of herpes simplex virus infection. Allergy. 2004;59:118–118.
    1. Cascaval RI Lancaster DJ Hypersensitivity syndrome associated with azithromycin. American Journal of Medicine. 2001;110:330–331.
    1. Odemis E Kalyoncu M Okten A Yildiz K. Azithromycin-induced leukocytoclastic vasculitis. Journal of Rheumatology. 2003;30:2292–2292.
    1. Cai Q Yang M Liu D Chen J Shu D Experimental treatment with favipiravir for COVID-19: An open-label control study. Engineering. 2020;10
    1. Wang Y Zhang D Du G Du R Zhao J Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial. Lancet. 2020;10:31022–9.
    1. Grein J Ohmagari N Shin D Diaz G Asperges E Compassionate use of remdesivir for patients with severe. Covid-19. New England Journal of Medicine. 2020;10
    1. Nordstrom BL Oh K Sacks ST L Skin reactions in patients with influenza treated with oseltamivir: a retrospective cohort study. Antiviral Therapy. 2004;9:187–195.
    1. Kalsi T Stevenson J Wade P Kinirons M. Tongue swelling in association with oseltamivir (Tamiflu) British Medical Journal Case Reports. 2011;10
    1. Smith EV Pynn MC Blackford S Leopold DJ Stevens-Johnson syndrome secondary to oseltamivir (Tamiflu) British Journal of General Practice. 2010;60:133–134.
    1. Zuo W Wen LP Li J Mei D Fu Q Zhang B Oseltamivir induced Stevens-Johnson syndrome/toxic epidermal necrolysis-case report. Medicine (Baltimore) 2019;98
    1. Luna P Zuazaga M Chede C Entin E Larralde M. Toxic epidermal necrolysis after treatment with oseltamivir. case report. Archivos Argentinos de Pediatria. 2010;108:e76–8.
    1. Calista D Maculo-papular rash induced by lopinavir/ritonavir. European Journal of Dermatology. 2005;15:97–98.
    1. Ghosn J Duvivier C Tubiana R Katlama C Acute generalized exanthematous pustulosis induced by HIV postexposure prophylaxis with lopinavir-ritonavir. Clinical Infectious Diseases. 2005;41:1360–1361.
    1. Cao B Wang Y Wen D Liu W Wang J Trial of lopinavir-ritonavir in adults hospitalized with severe. COVID-19. New England Journal of Medicine. 2020;382:1787–1799.

Source: PubMed

Sponsorer og samarbeidspartnere

Medisinsk tilstand

Legemiddelintervensjoner

3
Abonnere